Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      ‘We are going to run out’: Mitie marks eleventh mega takeover of 2026

      The FTSE 100 enjoyed a 3-year record rally in the third quarter.

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Manchester United accused of banning loyal fans to make space for big-spending tourists

      Excited football fans in a stadium, many wearing red shirts, cheering and holding up phones.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Will Ibai take home a Toast the City Award?

      CITY AM Toast the City Awards 2026 logo superimposed over an upscale bar and restaurant interior.

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

pascal soirot

  • Astrazeneca ploughs £300m into UK in surprise U-turn

    Pharma

    British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab after getting in a spat with the UK government over drug pricing. In a stunning volte-face, the UK’s largest pharmaceutical company said it would revive its £200m investment into a megalab [...]

    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca chief blasts Europe for ‘putting citizens’ health at risk’

    healthcare

    Europe is putting its “ability to protect the health of its own people at risk” by not investing enough, the chief executive of FTSE 100 giant Astrazeneca has warned. Pascal Soriot added that the continent is “falling behind” in attracting R&D and manufacturing investment and needs to “invest more in what really matters to it”. [...]

    The CEO of FTSE 100 giant Astrazeneca has spoken out. (Photo by Christopher Furlong/Getty Images)
  • How much is too much? The CEO pay predicament

    Pay

    A growing number of London-listed companies have been asking shareholders to approve radical pay rises for their top execs. Why?

    CEO pay is once again a hot topic in the City, but how much is too much?

Trending Articles

  • Romesh Ranganathan makes it hard to defend the BBC

  • Exclusive: Rugby World Champions Cup set to be mothballed

  • John Healey becomes Chancellor as Andy Burnham names top Cabinet appointments

  • Rachel Reeves’ sister takes top legal role in Burnham’s Cabinet overhaul

  • Revealed: KPMG and Deloitte offer bumper redundancy packages to slash headcount

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited